FDA NDC Directory · JSON-LD · Markdown

Dalfampridine

NDC 16729-292 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED, EXTENDED RELEASE

Labeler / ManufacturerAccord Healthcare Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA206863
Dosage form / routeTABLET, FILM COATED, EXTENDED RELEASE · ORAL
Active ingredientsDALFAMPRIDINE (10 mg/1)
Marketing started20180918
Package count1

External sources

Source: openFDA. Public-domain (CC0).